Inactivation of dipeptidyl peptidase iv attenuates the virulence of streptococcus suis serotype 2 that causes streptococcal toxic shock syndrome

Current Microbiology

Volumn 59, Issue 3, 2009, Pages 248-255

  Ge, Junchao ^a,b   Feng, Youjun ^c   Ji, Hongfeng ^a,b   Zhang, Huimin ^c   Zheng, Feng ^b   Wang, Changjun ^b   Yin, Zhimin ^a   Pan, Xiuzhen ^b   Tang, Jiaqi ^b  

^a NANJING NORMAL UNIVERSITY   (China)

^b Research Institute for Medicine of Nanjing Command   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; FIBRONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INACTIVATION; FEMALE; GENE DISRUPTION; GENE FUNCTION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; TOXIC SHOCK SYNDROME;

ANIMALS; BACTERIAL PROTEINS; CELL ADHESION; CELL LINE; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; FIBRONECTINS; GENE KNOCKOUT TECHNIQUES; GENETIC COMPLEMENTATION TEST; HUMANS; MICE; PROTEIN BINDING; SHOCK, SEPTIC; STREPTOCOCCUS SUIS; SURVIVAL ANALYSIS; VIRULENCE;

ANIMALIA; EUKARYOTA; STREPTOCOCCUS SUIS;

EID: 68849106529     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-009-9425-8     Document Type: Article

References (31)

1. L Baricault G Denariaz JJ Houri C Bouley C Sapin G Trugnan 1995 Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation Carcinogenesis 16 245 252
2. M Beaudoin R Higgins J Harel M Gottschalk 1992 Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates FEMS Microbiol Lett 78 111 116
3. A Beauvais M Monod J Wyniger JP Debeaupuis E Grouzmann N Brakch J Svab AG Hovanessian JP Latge 1997 Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans Infect Immun 65 3042 3047
4. N Charland V Nizet CE Rubens KS Kim S Lacouture M Gottschalk 2000 Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells Infect Immun 68 637 643
5. C Chen J Tang W Dong C Wang Y Feng J Wang F Zheng X Pan D Liu M Li Y Song X Zhu H Sun T Feng Z Guo A Ju J Ge Y Dong W Sun Y Jiang J Wang J Yan H Yang X Wang GF Gao R Yang J Wang J Yu 2007 A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates PLoS ONE 2 e315
6. Feng Y, Shi X, Zhang H, Zhang S, Ma Y, Zheng B, Han H, Lan Q, Tang J, Cheng J, Gao GF, Hu Q (2009) Recurrence of human Streptococcus suis infections in 2007: three cases of meningitis and implications that heterogeneous S. suis 2 circulates in China. Zoonoses Public Health (in press)
7. Y Feng F Zheng X Pan W Sun C Wang Y Dong AP Ju J Ge D Liu C Liu J Yan J Tang GF Gao 2007 Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis FEMS Microbiol Lett 275 80 88
8. Y Feng M Li H Zhang B Zheng H Han C Wang J Yan J Tang GF Gao 2008 Functional definition and global regulation of Zur, a zinc uptake regulator in a Streptococcus suis serotype 2 strain causing streptococcal toxic shock syndrome J Bacteriol 190 7567 7578
9. JM Goldstein A Banbula T Kordula JA Mayo J Travis 2001 Novel extracellular x-prolyl dipeptidyl-peptidase (DPP) from Streptococcus gordonii FSS2: an emerging subfamily of viridans Streptococcal x-prolyl DPPs Infect Immun 69 5494 5501
10. R Gupta SS Walunj RK Tokala KV Parsa SK Singh M Pal 2009 Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes Curr Drug Targets 10 71 87
11. JJ Holst 2004 Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors Expert Opin Emerg Drugs 9 155 166
12. MC Jobin D Grenier 2003 Identification and characterization of four proteases produced by Streptococcus suis FEMS Microbiol Lett 220 113 119
13. MC Jobin G Martinez J Motard M Gottschalk D Grenier 2005 Cloning, purification, and enzymatic properties of dipeptidyl peptidase IV from the swine pathogen Streptococcus suis J Bacteriol 187 795 799
14. M Kiyama M Hayakawa T Shiroza S Nakamura A Takeuchi Y Masamoto Y Abiko 1998 Sequence analysis of the Porphyromonas gingivalis dipeptidyl peptidase IV gene Biochim Biophys Acta 1396 39 46
15. Y Kumagai K Konishi T Gomi H Yagishita A Yajima M Yoshikawa 2000 Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence Infect Immun 68 716 724
16. Y Kumagai A Yajima K Konishi 2003 Peptidase activity of dipeptidyl aminopeptidase IV produced by Porphyromonas gingivalis is important but not sufficient for virulence Microbiol Immunol 47 735 743
17. M Li C Wang Y Feng X Pan G Cheng J Wang J Ge F Zheng M Cao Y Dong D Liu J Wang Y Lin H Du GF Gao X Wang F Hu J Tang 2008 SalK/SalR, a two-component signal transduction system, is essential for full virulence of highly invasive Streptococcus suis serotype 2 PLoS ONE 3 e2080
18. L Liu G Cheng C Wang X Pan Y Cong Q Pan J Wang F Zheng F Hu J Tang 2009 Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis Curr Microbiol 58 11 17
19. ZR Lun QP Wang XG Chen AX Li XQ Zhu 2007 Streptococcus suis: an emerging zoonotic pathogen Lancet Infect Dis 7 201 209
20. X Pan J Ge M Li B Wu C Wang J Wang Y Feng Z Yin F Zheng G Cheng W Sun H Ji D Hu P Shi X Feng X Hao R Dong F Hu J Tang 2009 The orphan response regulator CovR: a globally negative modulator of virulence in Streptococcus suis serotype 2 J Bacteriol 191 2601 2612
21. P Ruiz L Hao K Zucker N Zacharievich AL Viciana M Shenkin J Miller 1997 Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status Transpl Immunol 5 152 161
22. M Segura 2009 Streptococcus suis: an emerging human threat J Infect Dis 199 4 6
23. B Sinha PP Francois O Nusse M Foti OM Hartford P Vaudaux TJ Foster DP Lew M Herrmann KH Krause 1999 Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1 Cell Microbiol 1 101 117
24. S Sriskandan JD Slater 2006 Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East? PLoS Med 3 e187
25. JJ Staats I Feder O Okwumabua MM Chengappa 1997 Streptococcus suis: past and present Vet Res Commun 21 381 407
26. D Takamatsu M Osaki T Sekizaki 2001 Construction and characterization of Streptococcus suis-Escherichia coli shuttle cloning vectors Plasmid 45 101 113
27. J Tang C Wang Y Feng W Yang H Song Z Chen H Yu X Pan X Zhou H Wang B Wu H Wang H Zhao Y Lin J Yue Z Wu X He F Gao AH Khan J Wang GP Zhao Y Wang X Wang Z Chen GF Gao 2006 Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2 PLoS Med 3 e151
28. C Wang M Li Y Feng F Zheng Y Dong X Pan G Cheng R Dong D Hu X Feng J Ge D Liu J Wang M Cao F Hu J Tang 2009 The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2 Arch Microbiol 191 23 33
29. HF Wertheim HD Nghia W Taylor C Schultsz 2009 Streptococcus suis: an emerging human pathogen Clin Infect Dis 48 617 625
30. C Ye H Zheng J Zhang H Jing L Wang Y Xiong W Wang Z Zhou Q Sun X Luo H Du M Gottschalk J Xu 2009 Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis J Infect Dis 199 97 107
31. H Yu H Jing Z Chen H Zheng X Zhu H Wang S Wang L Liu R Zu L Luo N Xiang H Liu X Liu Y Shu SS Lee SK Chuang Y Wang J Xu W Yang 2006 Human Streptococcus suis outbreak, Sichuan, China Emerg Infect Dis 12 914 920